130 studies found for:    "Choroiditis"
Show Display Options
Rank Status Study
1 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
2 Completed Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Conditions: Vogt Koyanagi Harada Disease;   Serpiginous Choroiditis;   Multifocal Choroiditis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal Injection of Bevacizumab
3 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
4 Completed Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Conditions: Neovascularization;   Tuberculosis;   Multifocal Serpiginous Choroiditis;   Harada Toxoplasmosis
Intervention:
5 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
6 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
7 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
8 Not yet recruiting Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
Condition: Uveitis
Interventions: Drug: Simvastatin;   Drug: Placebo
9 Recruiting Optical Coherence Tomography (OCT) in Uveitis
Condition: Uveitis
Intervention:
10 Completed
Has Results
Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis
Condition: Chronic Uveitis
Intervention: Drug: infliximab
11 Unknown  Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
Conditions: Ocular Behcet's Disease,;   Non-Infectious Uveitis;   Refractory Uveitis
Intervention: Drug: flucinolone acetonide
12 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
13 Active, not recruiting Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
Condition: Uveitis
Intervention: Drug: Adalimumab
14 Unknown  Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Condition: Non-infectious Intermediate, Posterior, or Pan-uveitis.
Intervention: Drug: Tocilizumab
15 Active, not recruiting Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
Condition: Uveitis
Interventions: Other: Free strategy;   Other: Standardized strategy
16 Withdrawn Study of FTY720 in Patients With Uveitis
Condition: Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Interventions: Drug: FTY720;   Drug: Oral Corticosteroid
17 Completed Immune Indicators of Uveitis
Conditions: GITR;   GITR Ligand;   Uveitis;   Immunosuppression;   Suppressor of Cytokine Secretion
Intervention:
18 Recruiting Abatacept in the Treatment of Uveitis
Condition: Uveitis
Intervention: Drug: Abatacept
19 Enrolling by invitation An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data
Condition: Uveitis
Intervention: Drug: Dose 2 gevokizumab
20 Terminated Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis
Conditions: Sarcoid-associated Uveitis;   Ocular Sarcoidosis;   Macular Edema
Interventions: Drug: Methotrexate;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years